ArticleAnnals of internal medicine2023

In RA, new use of JAK inhibitors was associated with nonmelanoma skin cancer vs. TNF inhibitors at 2 y.

Ami SchattnerPubMed ↗Publisher ↗

No numbers read from the abstract.